Patent - Abbreviated New Drug Application Cases filed in the Third Circuit Courts
Cases 91 - 100 of 1,902
GALDERMA LABORATORIES, L.P. et al v. TARO PHARMACEUTICALS INC. et al
as 2:2024cv00333
Plaintiff: GALDERMA LABORATORIES, L.P., GALDERMA S.A., GALDERMA RESEARCH & DEVELOPMENT, S.N.C. and others
Defendant: TARO PHARMACEUTICALS INC., TARO PHARMACEUTICAL INDUSTRIES LTD. and TARO PHARMACEUTICALS U.S.A., INC.
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
AbbVie Inc. v. Hetero USA, Inc. et al
as 1:2023cv01332
Plaintiff: AbbVie Inc.
Defendant: Hetero USA, Inc., Hetero Labs Limited, Hetero Labs Limited Unit-V and others
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
AZURITY PHARMACEUTICALS, INC. v. AUROBINDO PHARMA LTD. et al
as 2:2023cv23273
Plaintiff: AZURITY PHARMACEUTICALS, INC.
Defendant: AUROBINDO PHARMA LTD. and AUROBINDO PHARMA USA, INC.
Cause Of Action: 15 U.S.C. § 1126 Patent Infringement
AXSOME MALTA LTD. et al v. UNICHEM LABORATORIES LTD.
as 2:2023cv23255
Plaintiff: AXSOME MALTA LTD. and AXSOME THERAPEUTICS, INC.
Defendant: UNICHEM LABORATORIES LTD.
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
GALDERMA LABORATORIES, L.P. et al v. TEVA PHARMACEUTICALS, INC. et al
as 2:2024cv00197
Plaintiff: GALDERMA LABORATORIES, L.P., GALDERMA S.A., GALDERMA RESEARCH & DEVELOPMENT, S.N.C. and others
Defendant: TEVA PHARMACEUTICALS, INC., TEVA PHARMACEUTICALS USA, INC., TEVA PHARMACEUTICALS INTERNATIONAL GMBH and others
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
Novo Nordisk Inc. et al v. Sun Pharmaceutical Industries Ltd. et al
as 1:2023cv01459
Plaintiff: Novo Nordisk Inc. and Novo Nordisk A/S
Defendant: Sun Pharmaceutical Industries Ltd. and Sun Pharmaceutical Industries, Inc.
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
Harmony Biosciences, LLC et al v. AET Pharma US, Inc. et al
as 1:2023cv01340
Plaintiff: Harmony Biosciences, LLC, Bioprojet Societe Civile de Recherche and Bioprojet Pharma SAS
Defendant: AET Pharma US, Inc., Annora Pharma Private Limited, Hetero USA, Inc. and others
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
AbbVie Inc. v. Teva Pharmaceuticals, Inc. et al
as 1:2023cv01268
Plaintiff: AbbVie Inc.
Defendant: Teva Pharmaceuticals, Inc. and Teva Pharmaceutical Industries Ltd.
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
Novartis Pharmaceuticals Corporation et al v. Novugen Oncology Sdn. Bhd. et al
as 1:2023cv01449
Plaintiff: Novartis Pharmaceuticals Corporation, Novartis Pharma AG and Japan Tobacco Inc.
Defendant: Novugen Oncology Sdn. Bhd., Novugen Pharma (USA) LLC and Makro Technologies, Inc.
Cause Of Action: 35 U.S.C. § 1 Patent Infringement
PURDUE PHARMA L.P. et al v ELITE LABORATORIES INC, et al.
as 1:2023cv22221
Plaintiff: PURDUE PHARMA L.P., PURDUE PHARMACEUTICALS L.P. and RHODES TECHNOLOGIES
Defendant: ELITE LABORATORIES, INC. and ELITE PHARMACEUTICALS, INC.
Cause Of Action: 35 U.S.C. § 271 Patent Infringement

Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.


Why Is My Information Online?